CD263 (TRAIL-R3) Monoclonal Antibody (TRAIL-R3-02), FITC | Invitrogen MA1-10161 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Invitrogen

other brands :

NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience

product type :

antibody

product name :

CD263 (TRAIL-R3) Monoclonal Antibody (TRAIL-R3-02), FITC

catalog :

MA1-10161

quantity :

100 ug

price :

US 437.00

clonality :

monoclonal

host :

mouse

conjugate :

FITC

clone name :

TRAIL-R3-02

The same clone is also sold as:

OriGene: AM03038AF-N, AM03038RP-N, AM03038FC-N
Exbio: 1P-518-C100, 10-518-C100, 1A-518-C100, 1F-518-C025, 1P-518-C025, 1F-518-C100, 10-518-C025

reactivity :

human

application :

flow cytometry

product information

Product Type :

Antibody

Product Name :

CD263 (TRAIL-R3) Monoclonal Antibody (TRAIL-R3-02), FITC

Catalog # :

MA1-10161

Quantity :

100 ug

Price :

US 437.00

Clonality :

Monoclonal

Purity :

Size-exclusion chromatography

Host :

Mouse

Reactivity :

Human

Applications :

Flow Cytometry: 1-5 ug/mL

Species :

Human

Clone :

TRAIL-R3-02

Isotype :

IgG1

Storage :

4 C, store in dark, DO NOT FREEZE!

Description :

TRAIL-R3 (CD263) is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.

Immunogen :

TRAIL-R3-hIgGhc fusion protein

Format :

Liquid

Applications w/Dilutions :

Flow Cytometry: 1-5 ug/mL

Aliases :

Antagonist decoy receptor for TRAIL/Apo-2L; CD263; cytotoxic TRAIL receptor-3; DCR1; DCR1-TNFR; Decoy receptor 1; decoy TRAIL receptor without death domain; LIT; lymphocyte inhibitor of TRAIL; MGC149501; MGC149502; TNF receptor superfamily member 10c; TNF-related apoptosis-inducing ligand receptor 3; TNFRSF10C; TRAIL receptor 3; TRAIL receptor without an intracellular domain; TRAILR3; TRAIL-R3; TRID; Tumor necrosis factor receptor superfamily member 10C; tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain; UNQ321/PRO366